221 related articles for article (PubMed ID: 32039627)
1. Suppression of αvβ6 downregulates P-glycoprotein and sensitizes multidrug-resistant breast cancer cells to anticancer drugs.
Zhang YH; Gao ZF; Dong GH; Li X; Wu Y; Li G; Wang AL; Li HL; Yin DL
Neoplasma; 2020 Mar; 67(2):379-388. PubMed ID: 32039627
[TBL] [Abstract][Full Text] [Related]
2. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
[TBL] [Abstract][Full Text] [Related]
3. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
Li C; Guan X; Xue H; Wang P; Wang M; Gai X
Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
[TBL] [Abstract][Full Text] [Related]
4. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
[TBL] [Abstract][Full Text] [Related]
7. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
[TBL] [Abstract][Full Text] [Related]
8. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
Dönmez Y; Gündüz U
Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
[TBL] [Abstract][Full Text] [Related]
11. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
[TBL] [Abstract][Full Text] [Related]
12. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway.
Wang W; Zou L; Zhou D; Zhou Z; Tang F; Xu Z; Liu X
Mol Carcinog; 2016 Sep; 55(9):1329-42. PubMed ID: 26293643
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.
Chen J; Ding Z; Peng Y; Pan F; Li J; Zou L; Zhang Y; Liang H
PLoS One; 2014; 9(6):e98882. PubMed ID: 24901645
[TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
16. Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs.
Sun Y; Zhang T; Gao P; Meng B; Gao Y; Wang X; Zhang J; Wang H; Wu X; Zheng W; Zhou G
Breast Cancer Res Treat; 2010 Jun; 121(3):591-9. PubMed ID: 19693666
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.
Kim HG; Hien TT; Han EH; Hwang YP; Choi JH; Kang KW; Kwon KI; Kim BH; Kim SK; Song GY; Jeong TC; Jeong HG
Br J Pharmacol; 2011 Mar; 162(5):1096-108. PubMed ID: 21054339
[TBL] [Abstract][Full Text] [Related]
18. γ-Tocotrienol reverses multidrug resistance of breast cancer cells through the regulation of the γ-Tocotrienol-NF-κB-P-gp axis.
Ding Y; Fan J; Fan Z; Zhang K
J Steroid Biochem Mol Biol; 2021 May; 209():105835. PubMed ID: 33556581
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein associates with Anxa2 and promotes invasion in multidrug resistant breast cancer cells.
Zhang F; Zhang H; Wang Z; Yu M; Tian R; Ji W; Yang Y; Niu R
Biochem Pharmacol; 2014 Jan; 87(2):292-302. PubMed ID: 24239898
[TBL] [Abstract][Full Text] [Related]
20. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs.
Jin W; Liu Y; Xu SG; Yin WJ; Li JJ; Yang JM; Shao ZM
Breast Cancer Res Treat; 2010 Nov; 124(1):39-48. PubMed ID: 20037778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]